Biotech Showcase 2025
13 January 202515 January 2025
California, USAHilton San Francisco Union Square
A premier investor conference committed to creating a platform for private and micro-mid-cap biotechnology companies, offering a unique opportunity to showcase innovations and engage one-to-one with investors and executives.
Biotech Showcase, along with its sister events, Seed Showcase and TechBio Showcase, is a dedicated investor conference designed to provide private and micro-mid-cap biotechnology companies.
With a roster of over 400 carefully selected presenting companies from across the globe, ranging from seed-stage startups to established multinational corporations, encompassing fields such as platform technologies, therapeutic areas, digital health, devices, and diagnostics, this eventsattract investors wielding over $400 billion in capital and motivated strategic partners within the life science ecosystem.
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze